Revolutionary Gene Therapy for Epidermolysis Bullosa on the Horizon

A clinical trial for a medication to treat a devastating skin condition that causes fragile skin and slow wound healing is showing promising results. The medication is a form of gene therapy that helps the skin produce collagen, and it has been tested on patients with the condition who have wounds that are difficult to heal. The trial involves dosing wounds with both the medication and a placebo to determine its effectiveness.